Home > PS Ratio > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
PS (Price/Sales) Ratio

The Current P/S Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 110.38.

Share Price ₹204.4Nov 22,2024
Market Cap ₹6,632.8 Cr
Sales-TTM₹60.1 CrTTM-Standalone Results
Price/Sales110.38xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

Definition & Calculation of PS (Price/Sales) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is calculated as :

Current Market Cap [ ₹6,632.8 Cr] as on Nov 22,2024

(/) Sales [ ₹60.1 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 110.38x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SUN PHARMA ADVANCED RESEARCH COMPANY , the investors are currently willing to pay '110.38 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SUN PHARMA ADVANCED RESEARCH COMPANY !

The chart below summarizes the trend in P/S Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY over the last five years.

Historical PS (Price/Sales) ratio chart of SUN PHARMA ADVANCED RESEARCH COMPANY


PS Ratio Performance Analysis for SUN PHARMA ADVANCED RESEARCH COMPANY

- SUN PHARMA ADVANCED RESEARCH COMPANY 's latest p/e ratio is 110.38x.

- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 57.94x.

- SUN PHARMA ADVANCED RESEARCH COMPANY 's operated at median p/e ratio of 32.92x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio peaked in Mar2024 at 158.92x.

- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio hit its five-year low in Mar2021 of 14.68x.


How does SUN PHARMA ADVANCED RESEARCH COMPANY 's P/S Ratio benchmark against top 10 peers in Business Support Industry?

Peer Comparison (Business Support Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SUN PHARMA ADVANCED RESEARCH COMPANY 60.1110.386,632.8
SYNGENE INTERNATIONAL LTD3,451.110.1434,996.6
LATENT VIEW ANALYTICS LTD725.212.669,180.3
JUST DIAL LTD1,042.98.759,129.1
DREAMFOLKS SERVICES LTD1,223.91.822,227.5
EKI ENERGY SERVICES LTD442.71.57696.9
AGS TRANSACT TECHNOLOGIES LTD1,414.40.69979.4
JAYKAY ENTERPRISES LTD85.516.821,438.1
QUINT DIGITAL LTD48.16.99335.7
PTL ENTERPRISES LTD64.48.29533.2
SWADESHI POLYTEX LTD54.67.75422.8

Business Support Industry Benchmark (Top 10) PS Analysis vs SUN PHARMA ADVANCED RESEARCH COMPANY 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 0.69x
Max industry PS 110.38x
Median industry PS 8.29x
Average industry PS 16.90x



You may also like the below Video Courses